Company Overview of Edge Therapeutics, Inc.
Key Executives for Edge Therapeutics, Inc.
|Brian A. Leuthner||11 Relationships||Co-Founder, Chief Executive Officer, President and Director||52|
|R. Loch MacDonald M.D., Ph.D.||11 Relationships||Co-Founder, Chief Scientific Officer and Director||55|
|Andrew Saik||No Relationships||Chief Financial Officer||48|
|Daniel Brennan||38 Relationships||Chief Operating Officer||49|
|Herbert J. Faleck D.O.||No Relationships||Chief Medical Officer||64|
|View More Key Executives|
Edge Therapeutics, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Sol J. Barer||89 Relationships||InspireMD, Inc.||70|
|Brian A. Leuthner||11 Relationships||Edge Therapeutics, Inc.||52|
|Isaac Blech||103 Relationships||YuanMing Capital||67|
|R. Loch MacDonald M.D., Ph.D.||11 Relationships||Edge Therapeutics, Inc.||55|
|Robert S. Langer Jr.||566 Relationships||InVivo Therapeutics Holdings Corp.||68|
Edge Therapeutics, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee CPA||James J. Loughlin||21 Relationships||3 Executives|
|Compensation Committee M.D., FACP||Robert J. Spiegel||47 Relationships||1 Executives|
|Advisory Board Jr.||Robert S. Langer||566 Relationships||1 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation||$467.5K|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.